Dr. Aurélie Jenn
Head of Regulatory Affairs and Quality Assurance
Dr. Aurélie Jenn, Head of Regulatory Affairs and Quality Assurance, is a pharmacist (Pharm. D) bringing over 20 years of experience in the pharmaceutical industry. In a first part of her career, she worked in Regulatory Affairs / CMC writing for generic products and New Chemical Entities in Switzerland and France, having close interactions and providing support to technical departments.
Dr. Christian Mittelholzer
Head of Project Management
Dr. Christian Mittelholzer, Head of Project Management, is a molecular biologist by training, with more than 15 years of experience in veterinary and human virology, and in the development of novel vaccines. After his Ph.D., performed at the Institute for Virology and Immunology in Mittelhäusern, Switzerland, Christian worked on several EU-funded research projects in Sweden and on Atlantic cod in Norway.
Dr. Christoph Heusser
Head of Immunology
Dr. Christoph Heusser, Head of Immunology, is an immunology expert who pioneered antibody-based therapies and antibody-mediated effector functions. He was Head of Immunology at Ciba-Geigy and Head of the Transplantation- Immunology Unit at Novartis and gave lectures on antibody-based interventions at the University Basel for 15 years.
Head of Human Resources
Michel Petignat, Head of Human Resources, is a qualified HR Specialist in the Life Sciences industry. During his long and outstanding professional career, Michel worked as an HR Manager in leading pharma and biotech companies such as Sandoz, Novartis Pharma, Syngenta Crop Protection and Actelion Pharmaceuticals.
Dr. Bernhard Hostettler
Head of Intellectual Property
Dr. Bernhard Hostettler, Head of Intellectual Property, originally is an organic chemist. After his Ph.D. at ETH Zürich, Bernhard was active in research for more than 20 years with companies Roche, CIBA, Syngenta and Givaudan.
Head of Clinical Operations
David Allman is a biochemist by training and has over 25 years of global experience in the pharmaceutical industry having worked for pharmaceutical companies and leading clinical research organizations as well as applying his expertise in the virtual development arena.
Dr. Robert Ettlin
Head of Preclinical Safety
Dr. Robert Ettlin is the Head of Preclinical Safety in Swiss Rockets. After some years in toxicological pathology at F. Hoffmann La Roche Ltd., Ettlin joined Sandoz Ltd. in Basel, where he advanced to Head of Toxicology and later Head of Development Operations Switzerland.
Dr. Zoltan Sümeghy
Project Leader Cell Culture Development
Dr. Zoltan Sümeghy holds a Ph.D. in Biochemistry from the Technical University of Budapest, where he previously studied Biochemical Engineering. Dr. Sümeghy started his career as a Lab Head at the Biotechnology Research Department, where he was responsible for USP development for all cell culture projects including scale-up, as well as for establishing the first development and GMP facility for cell cultures at Sandoz.
Dr. Martin Griot
Project Leader Cell Culture Manufacturing
Dr. Martin Griot is an experienced Senior Consultant with a demonstrated history of working in the biotechnology industry. He is highly skilled in pharmaceutics, oncology, biotechnology, biopharmaceuticals, and U.S. Food and Drug Administration (FDA).